Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Shifting focus to oncology, GSK recruits a cancer vet as new chief of US pharmaceuticals — adding another woman to ...
6 years ago
People
Boehringer follows the popular KRAS trail to MD Anderson — inks new alliance on 'virtual' research center
6 years ago
Deals
R&D
Key Apple digital health researcher set to join the Gates Foundation — report
6 years ago
People
R&D
BridgeBio CEO Neil Kumar engineers a deal to reel back Eidos shares. Or is he really hunting a buyout?
6 years ago
Deals
Humana takes aim at Mallinckrodt's 'ill-gotten' Acthar gains in lawsuit
6 years ago
Pharma
FDA+
FDA solicits industry input for OND policy priorities
6 years ago
FDA+
A top analyst spotlights a wave of biotech startups looking to catapult onto Nasdaq — or get bought out
6 years ago
Financing
Preferential tax policies coming for biopharmas setting up shop in Shanghai's newest free trade zone
6 years ago
China
Amgen attorneys win a megablockbuster patent case, dealing Novartis a severe setback on biosimilars play
6 years ago
Pharma
US senators accuse Novartis execs of greed for hiding manipulated Zolgensma data — and the next step could affect ...
6 years ago
Pharma
FDA+
Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes
6 years ago
People
FDA rejects Kala's dry eye drug; Troubled Insys finds a buyer (of some assets) in Hikma
6 years ago
News Briefing
Top Scripps scientist and biotech co-founder makes an abrupt — and unexplained — exit
6 years ago
R&D
Apple devices, in tandem with digital apps, could detect early signs of Alzheimer's, dementia: study
6 years ago
R&D
Melinta chief John Johnson jumps ship — with the chairman — from another troubled antibiotics play
6 years ago
People
Fabry disease: FDA drafts drug development guidance
6 years ago
FDA+
Amy Burroughs to lead Cleave Therapeutics; Cynthia Collins clinches Editas CEO job amid historic CRISPR move
6 years ago
Peer Review
AstraZeneca's flagship Tagrisso helps lung cancer patients live longer in pivotal study
6 years ago
R&D
Pharma
Mystery solved? Nektar chief says 'softening' in patient responses to bempeg was a CMC issue — spurring a rout
6 years ago
R&D
The FDA decides to hold an expert panel review of Vascepa after all — and Amarin shares tank on unexpected delay
6 years ago
R&D
FDA+
Sarepta shares slammed on report gene therapy Duchenne MD patient was hospitalized, but the company says it is ...
6 years ago
R&D
Pharma
Boris Johnson pledges £250M to spur AI adoption in NHS; SQZ scoops CFO Teri Loxam from Merck
6 years ago
News Briefing
New exec team, new money and a big syndicate — ORIC heads to PhII
6 years ago
R&D
Alexandria seals $143M deal in Seattle's 'heart of the heart,' grabbing coveted land to build its biotech cluster
6 years ago
Startups
First page
Previous page
933
934
935
936
937
938
939
Next page
Last page